Mass General Brigham
Startup rounds since 2014 with a Mass General Brigham investor on the board, and the firm's own fund filings.
Raises
33
since 2014
Unannounced
3
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Claris Biotherapeutics, Inc.$55.7M
- Claris Biotherapeutics, Inc.$2.3M
- CodaMetrix Inc.$11.6M
- Claris Biotherapeutics, Inc.$3.3M
- Mediar Therapeutics, Inc.$85M
- Claris Biotherapeutics, Inc.$10M
- SeQure Dx Inc.$2.18M
- SeQure Dx Inc.$2.61M
- Claris Biotherapeutics, Inc.$44.5M
- Abcuro, Inc.$120M
- Proximity Therapeutics, Inc.$11M
- Zielbio, Inc.$7.5M
- Nocion Therapeutics, Inc.$7M
- FireCyte Therapeutics, Inc.$5.5M
- SeQure Dx Inc.$17.5M
- Pykus Therapeutics, Inc.$2.49M
- Nocion Therapeutics, Inc.$15M
- Abcuro, Inc.$15.5M
- Albamunity, Inc.$5M
- Keros Therapeutics, Inc.$56M
- Zielbio, Inc.$11M
- Mediar Therapeutics, Inc.$5M
- Abcuro, Inc.$8M
- Keros Therapeutics, Inc.$11.5M
- Keros Therapeutics, Inc.$11M
- Tilos Therapeutics, Inc.$3.05M
- Abcuro, Inc.$2.25M
- Tilos Therapeutics, Inc.$750K
- InfoBionic, Inc.$8.2M
- Oscilla Power, Inc.$405K
- InfoBionic, Inc.$17M
- QPID, Inc.$12.3M
- Daktari Diagnostics, Inc.$20M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 1 | 0 |
| 2025 | 3 | 3 |
| 2024 | 2 | — |
| 2023 | 5 | — |
| 2022 | 3 | — |
| 2021 | 4 | — |
| 2020 | 2 | — |
| 2019 | 2 | — |
| 2018 | 2 | — |
| 2017 | 2 | — |
| 2016 | 3 | — |
| 2015 | 1 | — |
| 2014 | 3 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Mass General Brigham Fund III, L.P. | 1 Feb 2021 | $250M | — |
Listed because a Mass General Brigham fund's filing names a director of each company. A name match is not a verified identity.